Skip to main content

Table 3 Study accrual targets by race/ethnicity

From: Safety and tolerability study of sotrovimab (VIR-7831) prophylaxis against COVID-19 infection in immunocompromised individuals with impaired SARS-CoV-2 humoral immunity

Accrual targets

 

Sex/gender

Females

 

Males

 

Total

Ethnic category

 Hispanic or Latino

3

 + 

3

 = 

6

 Not Hispanic or Latino

43

 + 

44

 = 

87

Ethnic category: total of all subjects

46

 + 

47

 = 

93

Racial category

 American Indian or Alaskan Native

0

 + 

0

 = 

0

 Asian

2

 + 

2

 = 

4

 Black or African American

4

 + 

4

 = 

8

 Native Hawaiian or other Pacific Islander

0

 + 

0

 = 

0

 White

40

 + 

41

 = 

81

Racial category: total of all subjects

46

 + 

47

 = 

93

 

(A1 = A2)

 

(B1 = B2)

 

(C1 = C2)